Fa. Wollheim, PREDICTORS OF JOINT DAMAGE IN RHEUMATOID-ARTHRITIS, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 104(2), 1996, pp. 81-93
Rheumatoid arthritis (RA) is the dominant form of destructive chronic
arthritis with the potential to cause substantial disability and perma
nent functional impairment. The final extent and progression rate with
time, however, varies markedly In order to study effects of intervent
ion and to support early aggressive and atoxic therapy in selected cas
es, predictive disease markers are needed. Recent advances regarding j
oint tissue composition and pathophysiology have defined a number of b
iological marker candidates which need to be explored for possible pro
gnostic information. Some markers are characteristic for RA, such as r
heumatoid factors and certain autoantibodies, which although they are
more prevalent among patients with aggressive disease are not sensitiv
e as predictors in early disease. Genetic susceptibility markers have
been claimed to be good predictors of persisting arthritis in early sy
novitis clinics, but their role as severity markers in established dis
ease is limited. Unspecific markers of inflammation, notably ESR or CR
P when persistently elevated, are useful to monitor disease course and
newer markers need to document their superiority over these. Another
group of markers are attractive because of enriched or exclusive occur
rence in joint tissue, and altered metabolism in joint disease. Thus,
collagen type III propeptides, hyaluronates, and neopterin originating
in the synovium could be useful, and, in particular, hyaluronate leve
ls indeed do provide some predictive information. Highly tissue-specif
ic cartilage metabolites include aggrecan fragments, collagen II fragm
ents, cartilage oligomeric matrix protein (COMP) and the extraarticula
r cartilage matrix protein (CMP). When used alone or in combination in
early disease some information can be obtained which may in the futur
e facilitate prognostication. Bone metabolism can be monitored and the
re are different markers for synthesis and resorption. Meanwhile, whil
st the new markers are essential research tools, their routine clinica
l usefulness remains to be proven.